# FDA recall D-0100-2017

> **Allergan Sales, LLC** · Class II · drug recall initiated 2016-06-30.

## Product

TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manufactured by: Allergan Inc., Irvine, CA 92512. UPC: 300238335159.

## Reason for recall

Failed Content Uniformity Specifications

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0100-2017
- **Recalling firm:** Allergan Sales, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-06-30
- **Report date:** 2016-10-19
- **Termination date:** 2017-12-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Waco, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0100-2017

## Citation

> AI Analytics. FDA recall D-0100-2017. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-0100-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*